Bruker Corp (BRKR)

Common Shares

Sell: $46.78|Buy: $48.02|Change: 0.93 (-1.92%)

Open

$48.36

Previous close

$48.44

Trade high

$48.725

Volume

1,220,966

Year high

$64.64

Year low

$28.53

Dividend yield

0.41%

Market capitalisation

$7.22 bn

P/E ratio

74.31

ISIN

US1167941087

This share can be held in a Dealing account Stocks and shares ISA Lifetime ISA JISA SIPP

Share price

Dividends

	Previous	Latest
Record date	23/09/2025	08/12/2025
Ex-dividend date	23/09/2025	08/12/2025
Payment date	03/10/2025	02/01/2026
Amount	$0.05	$0.05

Performance 30/12/2025

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

	Total return (%)
Bruker Corp	- 1.92
More...

Company profile

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments(BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.

Sector

Healthcare

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.